---
title: "CIRC subsidiary China National Nuclear Corporation Haidewei submits IND application for BNCT boron drug"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/261769281.md"
description: "CIRC's subsidiary China Nuclear Huadewei has submitted an IND application for \"Injectable Boron [10B] Phenylalanine\" to the National Medical Products Administration. This drug has significant clinical advantages for refractory tumors, with a short treatment cycle and low side effects, representing the development direction of modern precision oncology"
datetime: "2025-10-19T11:57:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261769281.md)
  - [en](https://longbridge.com/en/news/261769281.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261769281.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/261769281.md) | [English](https://longbridge.com/en/news/261769281.md)


# CIRC subsidiary China National Nuclear Corporation Haidewei submits IND application for BNCT boron drug

China National Nuclear Corporation (01763.HK) announced that the information on the official website of the National Medical Products Administration's drug review center shows that the company's subsidiary, China Nuclear Haidewei, has publicly accepted the application for "Injectable Boron \[10B\] Phenylalanine."

The "Injectable Boron \[10B\] Phenylalanine" under research by China Nuclear Haidewei has significant clinical advantages for tumors that are insensitive to radiotherapy and chemotherapy, recurrent, refractory, infiltrative, in the middle to late stages, and locally metastatic. It has a short treatment course, low toxic side effects, and integrates diagnosis and treatment, representing the development direction and cutting-edge innovation of modern precision oncology

### 相關股票

- [CIRC (01763.HK)](https://longbridge.com/zh-HK/quote/01763.HK.md)

## 相關資訊與研究

- [Zhongtai Securities Sticks to Its Buy Rating for Wasion Holdings Limited (3393)](https://longbridge.com/zh-HK/news/281141455.md)
- [CICC Sticks to Its Buy Rating for CIMC Enric Holdings (CIMEF)](https://longbridge.com/zh-HK/news/281132485.md)
- [Guotai Haitong Remains a Buy on Jinxin Fertility Group Ltd. (1951)](https://longbridge.com/zh-HK/news/281098586.md)
- [CLSA Sticks to Their Buy Rating for China Merchants Bank Co (CIHHF)](https://longbridge.com/zh-HK/news/281093865.md)
- [WuXi XDC Cayman, Inc. (2268) Receives a Buy from Orient Securities](https://longbridge.com/zh-HK/news/280931364.md)